Nectar Lifesciences Ltd.

NECLIFE

₹23.1

-3.35% (-0.8)

Market Cap

₹536 Cr.

P/E

31.54

About

Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. NLL has transformed itself from being a small Domestic API p… Read more

Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Promoter Holding

Promoter has been buying shares from the open market over last 90 days
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Pledge

Promoters have pledged a significant portion of their holding
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Balance Sheet Strength

Balance sheet of the company is moderately strong
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

Global DMFs filed (.)
Source
Number of ANDA's Filed in USA (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

IOL Chemicals And Pharmaceuticals Ltd.

FAQs on Nectar Lifesciences Ltd. Business

What does Nectar Lifesciences do?

Nectar Lifesciences is a key player in the Indian Pharmaceutical Industry, specializing in Global Cephalosporins within Anti Infective Therapeutic segment. The company is expanding globally by entering regulated markets like US and European Union.

Who are the competitors of Nectar Lifesciences?

Nectar Lifesciences major competitors are SMS Lifesciences, NGL Fine-Chem, Everest Organics, Bal Pharma, Tyche Inds, Smruthi Organics, Mangalam Drugs&Org..
Market Cap of Nectar Lifesciences is ₹536 Crs.
While the median market cap of its peers are ₹173 Crs.

Is Nectar Lifesciences financially stable compared to its competitors?

Nectar Lifesciences seems to be less financially stable compared to its competitors.
Altman Z score of Nectar Lifesciences is 2.0 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Dec														Dec
Investor Presentation		Sep Dec
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Nectar Lifesciences Ltd.